Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells

Molecular Biotechnology

Volumn 55, Issue 2, 2013, Pages 169-178

  Madonna, Rosalinda ^a,b   Görbe, Aniko ^d,e   Ferdinandy, Peter ^c,d   De Caterina, Raffaele ^b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF CHIETI   (Italy)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d PHARMAHUNGARY GROUP   (Hungary)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Biophysical factors; Diabetes; Glucose; Hyperosmolarity; Induced pluripotent stem cells; Oxygen

Indexed keywords

BIOPHYSICAL FACTORS; CLINICAL APPLICATION; EXTRACELLULAR MEDIUM; HYPEROSMOLARITY; INDUCED PLURIPOTENT STEM CELLS; MITOCHONDRIAL BIOGENESIS; PLURIPOTENT STEM CELLS; REGULATORY ELEMENTS;

GLUCOSE; MEDICAL PROBLEMS; METABOLISM; OXYGEN; PHYSIOLOGY; TOOLS;

STEM CELLS;

ACETYL COENZYME A; ALDEHYDE DEHYDROGENASE; APOLIPOPROTEIN E; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENOLASE; F ACTIN; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER; GLUTATHIONE PEROXIDASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOKINASE; HISTONE DEACETYLASE; LACTATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PYRUVATE DEHYDROGENASE; PYRUVATE KINASE;

ACTIN POLYMERIZATION; ANAEROBIC GLYCOLYSIS; ANGIOGENESIS; APOPTOSIS; CELL CONTACT; CELL DIFFERENTIATION; CELL FATE; CELL MEMBRANE; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DIABETES MELLITUS; ENERGY METABOLISM; ENERGY RESOURCE; ENERGY YIELD; EXTRACELLULAR SPACE; FLOW CYTOMETRY; GENE EXPRESSION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; HYPEROSMOLARITY; HYPEROSMOTIC STRESS; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEAR REPROGRAMMING; OSMOLARITY; OXIDATIVE PHOSPHORYLATION; PLURIPOTENT STEM CELL; REVIEW; SMOOTH MUSCLE FIBER; SOMATIC CELL;

IPS;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SURVIVAL; ENERGY METABOLISM; GLUCOSE; HUMANS; HYPERGLYCEMIA; INDUCED PLURIPOTENT STEM CELLS; MITOCHONDRIA; NUCLEAR REPROGRAMMING; OSMOTIC PRESSURE; OXYGEN; PLURIPOTENT STEM CELLS;

EID: 84888202910     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-013-9668-2     Document Type: Review

References (96)

1. Almeida, A.; Bolanos, J. P.; et al. (2010). E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proceedings of the National Academy of Sciences of the United States of America, 107(2), 738-741.
2. Ambasudhan, R.; Talantova, M.; et al. (2011). Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell, 9(2), 113-118.
3. Angele, P.; Yoo, J. U.; et al. (2003). Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro. Journal of Orthopaedic Research, 21(3), 451-457.
4. Armstrong, L.; Tilgner, K.; et al. (2011). Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells, 28(4), 661-673.
5. Awad, H. A.; Wickham, M. Q.; et al. (2004). Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials, 25(16), 3211-3222.
6. Balaban, N. Q.; Schwarz, U. S.; et al. (2001). Force and focal adhesion assembly: A close relationship studied using elastic micropatterned substrates. Nature Cell Biology, 3(5), 466-472.
7. Bar-Even, A.; Flamholz, A.; et al. (2010). Rethinking glycolysis: On the biochemical logic of metabolic pathways. Nature Chemical Biology, 8(6), 509-517.
8. Batten, B. E.; Albertini, D. F.; et al. (1987). Patterns of organelle distribution in mouse embryos during preimplantation development. American Journal of Anatomy, 178(2), 204-213.
9. Beningo, K. A.; Dembo, M.; et al. (2001). Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. Journal of Cell Biology, 153(4), 881-888.
10. Blundell, M. P.; Demaison, C.; et al. (1999). Quality of repopulation in nonobese diabetic severe combined immunodeficient mice engrafted with expanded cord blood CD34+ cells. Blood, 94(9), 3269-3270.
11. Bogan, J. S. (2012). Regulation of glucose transporter translocation in health and diabetes. Annual Review of Biochemistry, 81, 507-532.
12. Bolanos, J. P.; Almeida, A.; et al. (2010). Glycolysis: A bioenergetic or a survival pathway? Trends in Biochemical Sciences, 35(3), 145-149.
13. Caiazzo, M.; Dell'anno, M. T.; et al. (2011). Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature, 476(7359), 224-227.
14. Chen, C. S.; Alonso, J. L.; et al. (2003). Cell shape provides global control of focal adhesion assembly. Biochemical and Biophysical Research Communications, 307(2), 355-361.
15. Chen, Y. H.; Lin, S. J.; et al. (2007). High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes, 56(6), 1559-1568.
16. Chicurel, M. E.; Chen, C. S.; et al. (1998). Cellular control lies in the balance of forces. Current Opinion in Cell Biology, 10(2), 232-239.
17. Covello, K. L.; Kehler, J.; et al. (2006). HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes & Development, 20(5), 557-570.
18. Cubbon, R. M.; Kahn, M. B.; et al. (2009). Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clinical Science (London), 117(5), 173-190.
19. Denker, H. W. (2006). Potentiality of embryonic stem cells: An ethical problem even with alternative stem cell sources. Journal of Medical Ethics, 32(11), 665-671.
20. Deschepper, M.; Oudina, K.; et al. (2011). Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia. Journal of Cellular and Molecular Medicine, 15(7), 1505-1514.
21. Dike, L. E.; Chen, C. S.; et al. (1999). Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cellular and Developmental Biology, 35(8), 441-448.
22. Egan, C. G.; Lavery, R.; et al. (2008). Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. Diabetologia, 51(7), 1296-1305.
23. Facucho-Oliveira, J. M.; St John, J. C. (2009). The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation. Stem Cell Review, 5(2), 140-158.
24. Fadini, G. P.; Miorin, M.; et al. (2005). Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. Journal of the American College of Cardiology, 45(9), 1449-1457.
25. Fadini, G. P.; Pucci, L.; et al. (2007). Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia, 50(10), 2156-2163.
26. Felice, F.; Lucchesi, D.; et al. (2010). Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells: Evidence for differential glutathione peroxidase-1 expression. Microvascular Research, 80(3), 332-338.
27. Folkman, J.; Moscona, A. (1978). Role of cell shape in growth control. Nature, 273(5661), 345-349.
28. Folmes, C. D.; Nelson, T. J.; et al. (2011). Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metabolism, 14(2), 264-271.
29. Fu, J.; Tay, S. S.; et al. (2006). High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells. Diabetologia, 49(5), 1027-1038.
30. Gallagher, K. A.; Liu, Z. J.; et al. (2007). Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. Journal of Clinical Investigation, 117(5), 1249-1259.
31. Gong, Z.; Niklason, L. E. (2008). Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB Journal, 22(6), 1635-1648.
32. Görbe, A.; Varga, Z. V.; et al. (2013). Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes. Int J Immunopathol Pharmacol in press.
33. Gordan, J. D.; Bertout, J. A.; et al. (2007). HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell, 11(4), 335-347.
34. Gordan, J. D.; Thompson, C. B.; et al. (2007). HIF and c-Myc: Sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell, 12(2), 108-113.
35. Guilak, F.; Cohen, D. M.; et al. (2009). Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell, 5(1), 17-26.
36. Han, J. K.; Lee, H. S.; et al. (2008). Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Circulation, 118(10), 1021-1033.
37. Hoben, G. M.; Koay, E. J.; et al. (2008). Fibrochondrogenesis in two embryonic stem cell lines: Effects of differentiation timelines. Stem Cells, 26(2), 422-430.
38. Huang, C. Y.; Hagar, K. L.; et al. (2004). Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells, 22(3), 313-323.
39. Hwang, N. S.; Varghese, S.; et al. (2007). Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. Journal of Cellular Physiology, 212(2), 281-284.
40. Hwang, N. S.; Varghese, S.; et al. (2006). Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate- modified hydrogels. Tissue Engineering, 12(9), 2695-2706.
41. Ieda, M.; Fu, J. D.; et al. (2010). Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell, 142(3), 375-386.
42. Ingber, D. (1991). Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis. Journal of Cellular Biochemistry, 47(3), 236-241.
43. Ingber, D. E. (2006). Cellular mechanotransduction: Putting all the pieces together again. FASEB Journal, 20(7), 811-827.
44. Jang, Y. Y.; Sharkis, S. J. (2007). A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood, 110(8), 3056-3063.
45. Johnson, C. P.; Tang, H. Y.; et al. (2007). Forced unfolding of proteins within cells. Science, 317(5838), 663-666.
46. Kawamura, T.; Suzuki, J.; et al. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 460(7259), 1140-1144.
47. Kloxin, A. M.; Kasko, A. M.; et al. (2009). Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science, 324(5923), 59-63.
48. Krankel, N.; Adams, V.; et al. (2005). Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arteriosclerosis Thrombosis and Vascular Biology, 25(4), 698-703.
49. Le Belle, J. E.; Orozco, N. M.; et al. (2011). Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell, 8(1), 59-71.
50. Leeper, N. J.; Hunter, A. L.; et al. (2012). Stem cell therapy for vascular regeneration: Adult, embryonic, and induced pluripotent stem cells. Circulation, 122(5), 517-526.
51. Lehninger, A. L. (1971). Biochemistry and human welfare: Where now and whither? Federation Proceedings, 30(4), 1397-1402.
52. Leto, D.; Saltiel, A. R. (2012). Regulation of glucose transport by insulin: Traffic control of GLUT4. Nature Reviews Molecular Cell Biology, 13(6), 383-396.
53. Loomans, C. J.; de Koning, E. J.; et al. (2004). Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 53(1), 195-199.
54. Lum, J. J.; Bui, T.; et al. (2007). The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes & Development, 21(9), 1037-1049.
55. Lunt, S. Y.; Vander Heiden, M. G. (2011). Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annual Review of Cell and Developmental Biology, 27, 441-464.
56. Ly, D. L.; Waheed, F.; et al. (2013). Hyperosmotic stress regulates the distribution and stability of myocardin-related transcription factor, a key modulator of the cytoskeleton. American Journal of Physiology, 304(2), C115-C127.
57. Madonna, R. (2012). Human-induced pluripotent stem cells: In quest of clinical applications. Molecular Biotechnology, 52(2), 193-203.
58. Madonna, R.; Geng, Y. J.; et al. (2009). Adipose tissue-derived stem cells: Characterization and potential for cardiovascular repair. Arteriosclerosis Thrombosis and Vascular Biology, 29(11), 1723-1729.
59. Madonna, R.; Shelat, H.; et al. (2011). Aquaporin-1 is required for vascular development of human induced pluripotent stem cells following exposure to glucose-induced hyperosmolarity. Circulation AOS.701.01 (Abstract Oral Session).
60. Manasek, F. J.; Burnside, M. B.; et al. (1972). Myocardial cell shape change as a mechanism of embryonic heart looping. Developmental Biology, 29(4), 349-371.
61. Mauck, R. L.; Yuan, X.; et al. (2006). Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage, 14(2), 179-189.
62. McBride, H. M.; Neuspiel, M.; et al. (2006). Mitochondria: More than just a powerhouse. Current Biology, 16(14), R551-R560.
63. McBride, S. H.; Falls, T.; et al. (2008). Modulation of stem cell shape and fate B: Mechanical modulation of cell shape and gene expression. Tissue Engineering Part A, 14(9), 1573-1580.
64. Mylotte, L. A.; Duffy, A. M.; et al. (2008). Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells, 26(5), 1325-1336.
65. Nelson, C. M.; Jean, R. P.; et al. (2005). Emergent patterns of growth controlled by multicellular form and mechanics. Proceedings of the National Academy of Sciences of the United States of America, 102(33), 11594-11599.
66. Niklason, L. E.; Gao, J.; et al. (1999). Functional arteries grown in vitro. Science, 284(5413), 489-493.
67. O'Cearbhaill, E. D.; Punchard, M. A.; et al. (2008). Response of mesenchymal stem cells to the biomechanical environment of the endothelium on a flexible tubular silicone substrate. Biomaterials, 29(11), 1610-1619.
68. Panopoulos, A. D.; Yanes, O.; et al. (2011). The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Research, 22(1), 168-177.
69. Prigione, A.; Adjaye, J. (2011). Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. International Journal of Developmental Biology, 54(11-12), 1729-1741.
70. Rafalski, V. A.; Mancini, E.; et al. (2012). Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate. Journal of Cell Science, 125(Pt 23), 5597-5608.
71. Rao, M.; Condic, M. L. (2008). Alternative sources of pluripotent stem cells: Scientific solutions to an ethical dilemma. Stem Cells and Development, 17(1), 1-10.
72. Raya, A.; Rodriguez-Piza, I.; et al. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 460(7251), 53-59.
73. Riveline, D.; Zamir, E.; et al. (2001). Focal contacts as mechanosensors: Externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. Journal of Cell Biology, 153(6), 1175-1186.
74. Saitoh, S.; Takahashi, I.; et al. (2000). Compressive force promotes chondrogenic differentiation and hypertrophy in midpalatal suture cartilage in growing rats. Anatomical Record, 260(4), 392-401.
75. Sawada, Y.; Tamada, M.; et al. (2006). Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell, 127(5), 1015-1026.
76. Schupp, M.; Lazar, M. A. (2010). Fingered for a fat fate. Cell Metabolism, 11(4), 244-245.
77. Seeger, F. H.; Haendeler, J.; et al. (2005). p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation, 111(9), 1184-1191.
78. Sniadecki, N. J.; Anguelouch, A.; et al. (2007). Magnetic microposts as an approach to apply forces to living cells. Proceedings of the National Academy of Sciences of the United States of America, 104(37), 14553-14558.
79. Sordella, R.; Jiang, W.; et al. (2003). Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell, 113(2), 147-158.
80. Spinetti, G.; Kraenkel, N.; et al. (2008). Diabetes and vessel wall remodelling: From mechanistic insights to regenerative therapies. Cardiovascular Research, 78(2), 265-273.
81. Su, Y.; Liu, X. M.; et al. (2008). Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus. American Journal of Cardiology, 102(4), 497-498.
82. Sukharev, S.; Corey, D. P. (2004). Mechanosensitive channels: Multiplicity of families and gating paradigms. Science's STKE, 2004(219), re4.
83. Takahashi, K.; Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663-676.
84. Tan, J. L.; Tien, J.; et al. (2003). Cells lying on a bed of microneedles: An approach to isolate mechanical force. Proceedings of the National Academy of Sciences of the United States of America, 100(4), 1484-1489.
85. Tepper, O. M.; Galiano, R. D.; et al. (2002). Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 106(22), 2781-2786.
86. Varum, S.; Rodrigues, A. S.; et al. (2011). Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS ONE, 6(6), e20914.
87. Vats, A.; Bielby, R. C.; et al. (2005). Stem cells. Lancet, 366(9485), 592-602.
88. Wang, H.; Riha, G. M.; et al. (2005). Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arteriosclerosis Thrombosis and Vascular Biology, 25(9), 1817-1823.
89. Westfall, S. D.; Sachdev, S.; et al. (2008). Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells and Development, 17(5), 869-881.
90. Yamamoto, K.; Sokabe, T.; et al. (2005). Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. American Journal of Physiology, 288(4), H1915-H1924.
91. Yang, Y.; Relan, N. K.; et al. (1999). Embryonic mesenchymal cells share the potential for smooth muscle differentiation: Myogenesis is controlled by the cell's shape. Development, 126(13), 3027-3033.
92. Ye, Z.; Zhan, H.; et al. (2009). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood, 114(27), 5473-5480.
93. Yoshida, Y.; Takahashi, K.; et al. (2009). Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 5(3), 237-241.
94. Zheng, H.; Dai, T.; et al. (2008). SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis, 201(1), 36-42.
95. Zheng, H.; Shen, C. J.; et al. (2010). Stromal cell-derived factor 1alpha reduces senescence of endothelial progenitor subpopulation in lectin-binding and DiLDL-uptaking cell through telomerase activation and telomere elongation. Journal of Cellular Physiology, 223(3), 757-763.
96. Zhu, S.; Li, W.; et al. (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell, 7(6), 651-655.